Macular Degeneration: all 1,490 studies
Page 11 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMDCompletedNCT02321241
- A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular DegenerationCompletedNCT02314299Phase 1/2
- The Impact of Ocular Diseases on Driving: a Prospective StudyCompletedNCT02313259
- Intravitreal Aflibercept in Neovascular AMD With Limited Response to RanibizumabCompletedNCT02309281Phase 4
- Retinal Therapy Guided by 3D OCT Image AnalysisCompletedNCT02308215
- The Accuracy of Home Monitoring for Acute Macular Degeneration (AMD) Disease ActivityCompletedNCT02304068Not applicable
- Prophylactic Ranibizumab for Exudative Age-Related Macular DegenerationCompletedNCT02302989Phase 1/2
- Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration PatientsStatus unknownNCT02296567Phase 2/3
- Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to AfliberceptCompletedNCT02291887
- Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in ItalyCompletedNCT02289924
- Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic TreatmentCompletedNCT02287298
- Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMDCompletedNCT02279537
- Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants SupplementationCompletedNCT02264938Not applicable
- Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic RetinopathyCompletedNCT02261194Not applicable
- NVAMD Satellite StudyCompletedNCT02251366Not applicable
- Association of Previously Verified Gene Polymorphisms With AMD in Turkish PopulationStatus unknownNCT02248324
- Stereotactic Radiotherapy for Wet AMD (STAR)CompletedNCT02243878Phase 3
- Phase 1 Safety Study of ALK-001 in Healthy VolunteersCompletedNCT02230228Phase 1
- Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)TerminatedNCT02228304Phase 1/2
- Argus II Retinal Prosthesis System Dry AMD Feasibility Study ProtocolCompletedNCT02227498Not applicable
- Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198TerminatedNCT02226835
- The Focal Electro-Oculogram in Macular DiseaseCompletedNCT02225119
- Macular Degeneration and Aging StudyCompletedNCT02224963Not applicable
- Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMDCompletedNCT02218177
- Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular DegenerationCompletedNCT02204683Phase 1
- A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.CompletedNCT02174211Not applicable
- Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase IStatus unknownNCT02173873Phase 1
- Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR)CompletedNCT02173496
- Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases.CompletedNCT02162953
- Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)CompletedNCT02142296Phase 4
- Prophylactic Ranibizumab for Exudative Age-related Macular DegenerationCompletedNCT02140151Phase 1/2
- Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular DegenerationTerminatedNCT02137915
- Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular DegenerationCompletedNCT02130531Phase 1
- Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular DegenerationStatus unknownNCT02127463Phase 2/3
- Resistance to Antibiotics in Patients Receiving Eye InjectionsCompletedNCT02126423
- Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of AfliberceptCompletedNCT02125864Phase 4
- Research With Retinal Cells Derived From Stem Cells for Myopic Macular DegenerationWithdrawnNCT02122159Phase 1/2
- Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular DegenerationCompletedNCT02121353Phase 1/2
- The Role of Complement Factor H Polymorphism in the Regulation of Choroidal Vascular Tone in Young Healthy SubjectsStatus unknownNCT02102880Not applicable
- An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD)Status unknownNCT02098720Phase 2
- Development of a Device to Measure Dark AdaptationCompletedNCT02090751
- Monocentric Retrospective Observational Study on Patients With Macular DegenerationStatus unknownNCT02089503
- Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the RetinaTerminatedNCT02088151Not applicable
- Analysis of Aqueous and Vitreous HumorStatus unknownNCT02067013Phase 2
- Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMDCompletedNCT02061865Phase 1
- Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular DegenerationCompletedNCT02060604Phase 4
- Mobile Clinic - a Cross-sectional Epidemiological SurveyCompletedNCT02055612
- Directional Spread in Geographic AtrophyCompletedNCT02051998
- Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular DegenerationWithdrawnNCT02036723Phase 3
- Intravitreal Injections-related AnxietyCompletedNCT02035722Phase 2/3
- Vision Measured by the Vimetrics CVA Compared With Chart Testing Under Similar Luminance and Contrast ConditionsCompletedNCT02028351
- Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular DegenerationWithdrawnNCT02024269Not applicable
- Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMDCompletedNCT02022540Phase 1
- A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular DegenerationCompletedNCT02022501Phase 1/2
- Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular DegenerationStatus unknownNCT02016508Phase 1/2
- A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology ClinicsTerminatedNCT02005133
- Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab InjectionsTerminatedNCT02002377Phase 4
- Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)CompletedNCT01997164Phase 1
- Brain Connectivity in Age-Related Macular DegenerationCompletedNCT01996215
- TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) InjectionTerminatedNCT01983579Phase 4
- Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.CompletedNCT01972763Phase 1/2
- Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910Status unknownNCT01961414Phase 4
- Treatment of AMD With Rheohemapheresis /RHF/Status unknownNCT01943396Phase 4
- Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.CompletedNCT01942213
- A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular DegenerationCompletedNCT01941082Phase 1
- Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular DegenerationCompletedNCT01933152
- Safety Study of a Topical Treatment for Dry Age Related Macular DegenerationCompletedNCT01922128Phase 1
- Stem Cell Ophthalmology Treatment StudyStatus unknownNCT01920867Not applicable
- Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.Status unknownNCT01918878Phase 4
- Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing FactorsCompletedNCT01918553Not applicable
- Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease StudyCompletedNCT01915238
- Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular DegenerationCompletedNCT01914380
- Time to Treatment Utilizing a Tele-Retinal Referral System for wAMD and DME: A Pilot StudyCompletedNCT01899963
- Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth FactorCompletedNCT01896284Phase 4
- Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMDCompletedNCT01880788
- Living Successfully With Chronic Eye DiseasesStatus unknownNCT01879501Not applicable
- Visual and Functional Assessment in Low Vision PatientsCompletedNCT01876147
- Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)CompletedNCT01863199Phase 4
- Intravitreal Anti-VEGF in Exudative AMD With Epiretinal MembranesCompletedNCT01846351
- HELP Therapy for Dry AMDCompletedNCT01840683Not applicable
- Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMDCompletedNCT01835067Phase 2/3
- Proton Radiation Therapy for Macular DegenerationCompletedNCT01833325Not applicable
- Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.CompletedNCT01831947Phase 4
- Risk Factors for Drusen ProgressionWithdrawnNCT01830608
- Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular DegenerationCompletedNCT01824225Phase 4
- Study on Visual Function Impairments in Dry Age-related Macular DegenerationCompletedNCT01822873
- Micropulse Laser for Geographic AtrophyCompletedNCT01799564Not applicable
- Laser Intervention in Early Age-Related Macular Degeneration StudyCompletedNCT01790802Not applicable
- Eylea Post Marketing Surveillance(PMS)CompletedNCT01783925
- Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)CompletedNCT01782989Phase 2/3
- AMD Phenotype and Genotype StudyCompletedNCT01778491
- Impact of Visceral Fat on the Pathogenesis of Age-related Macular DegenerationStatus unknownNCT01777984
- Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF TherapyCompletedNCT01771081
- EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in JapanCompletedNCT01756261
- EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in JapanCompletedNCT01756248
- A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular DegenerationCompletedNCT01749891Phase 1/2
- A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in EyesTerminatedNCT01746875Not applicable
- Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular DegenerationWithdrawnNCT01731964Not applicable
- Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular ImagingTerminatedNCT01717937
- Life Style and Food Habits Questionnaire in the Portuguese Population Aged 55 or MoreCompletedNCT01715870